What is the main purpose of clinical trials in drug development?

• A. Market viability of a candidate drug
• B. PK/PD information in humans
• C. Manufacturing costs across suppliers
• D. Patient satisfaction with existing therapies

Answer: (B)

Understanding how a drug behaves in the body and what it does at different doses is the core aim of clinical trials. This means collecting pharmacokinetic data—how the body absorbs, distributes, metabolizes, and eliminates the drug—to describe concentration over time, the exposure a patient experiences, and how long the drug stays in the system. It also means gathering pharmacodynamic information—how the drug’s concentration relates to its therapeutic effects and potential adverse effects. Together, PK/PD data in humans inform dose selection, dosing schedules, and safety considerations, which are essential for determining an effective and safe regimen and for regulatory submissions.

Other aspects like market viability, manufacturing costs, or patient satisfaction with existing therapies are important in broader drug development and commercialization, but they are not the principal objective of clinical trials, which focus on safety, efficacy, and dosing in people.